Drug-coated balloons market seen reaching $2.55B by 2030

The Business Research Company says the global drug-coated balloons market will grow from $1.24 billion in 2025 to $2.55 billion by 2030, driven by cardiovascular demand, interventional cardiology use and stent-free therapies. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Drug-coated balloons are used to open narrowed or blocked blood vessels while delivering medication at the treatment site. - The category is benefiting from demand for restenosis prevention and minimally invasive vascular procedures. - Faster growth in ambulatory surgery centers could expand use because drug-coated balloons can shorten procedure times and improve throughput.

What happened: - The Business Research Company projected the global drug-coated balloons market will rise from $1.24 billion in 2025 to $1.43 billion in 2026. - The firm forecast the market will reach $2.55 billion by 2030. - The report put the market’s 2025-2030 CAGR at 15.6%. - North America held the largest share of the global market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - The market’s recent growth has been tied to rising cardiovascular disease prevalence, more interventional cardiology procedures, early adoption of paclitaxel-coated balloons and improvements in angioplasty methods. - Future growth is linked to greater use of drug-coated balloon therapies in coronary interventions, next-generation coating technologies, more catheter-based treatments and higher investment in vascular innovation. - The report identified sirolimus-coated balloons, peripheral artery disease use, minimally invasive vascular procedures, drug-coating advances and better drug delivery efficiency as major trends. - The Business Research Company said drug-coated balloons are specialized medical devices used in interventional cardiology and radiology. - The device combines angioplasty with localized drug delivery to help restore blood flow and reduce restenosis. - The market analysis covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company offered a free sample report and a full market report.

Between the lines: - The forecast points to sustained demand for stent-free treatment options in cardiovascular care. - The ambulatory surgery center trend suggests providers may favor devices that support faster workflows and lower operating costs. - The report’s emphasis on new coating technologies shows the market is still evolving around drug delivery performance.

What's next: - The Business Research Company expects growth to continue through 2030 as coronary and peripheral vascular use cases expand. - The report highlighted broader adoption of next-generation coatings and catheter-based therapies as likely market drivers. - Asia-Pacific’s projected growth could narrow the gap with North America if adoption continues to accelerate.

The bottom line: - Drug-coated balloons are moving from a niche vascular tool to a faster-growing part of interventional care, with the market projected to more than double by 2030.